A physiologically based model of creatine kinase-MB release in reperfusion of acute myocardial infarction
- 1 July 1989
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 64 (1) , 11-15
- https://doi.org/10.1016/0002-9149(89)90645-0
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Usefulness of a rapid initial increase in plasma creatine kinase activity as a marker of reperfusion during thrombolytic therapy for acute myocardial infarctionThe American Journal of Cardiology, 1988
- Detection of coronary artery reperfusion with creatine kinase-MB determinations during thrombolytic therapy: Correlation with acute angiographyJournal of the American College of Cardiology, 1988
- Peak creatine kinase as a measure of effectiveness of thrombolytic therapy in acute myocardial infarctionThe American Journal of Cardiology, 1987
- Time Course of Serum Cardiac Enzymes After Intracoronary Thrombolytic TherapyArchives of internal medicine (1960), 1985
- Left Ventricular Function and Rapid Release of Creatine Kinase MB in Acute Myocardial InfarctionNew England Journal of Medicine, 1983
- Coronary thrombolysis: Some unresolved issuesThe American Journal of Medicine, 1982
- Intracoronary thrombolysis in evolving myocardial infarctionAmerican Heart Journal, 1981
- Correlation of radionuclide estimates of myocardial infarction size and release of creatine kinase-MB in man.Circulation, 1980
- Effects of Coronary Artery Reperfusion on Myocardial Infarct Size Calculated from Creatine KinaseJournal of Clinical Investigation, 1978
- The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs.Circulation, 1977